Influence of renal denervation on renal effects of acute nitric oxide and ETA/ETB receptor inhibition in conscious normotensive rats.
The role of renal nerves in the effects of concomitant NO synthase and non-selective ET(A/)ET(B) receptor inhibition on renal function was investigated in conscious normotensive Wistar rats. NO synthase inhibition alone (10 mg/kg b. w. i.v. L-NAME) in sham-operated rats with intact renal nerves induced an increase in systolic, diastolic and mean arterial pressure, urine flow rate, sodium, chloride and calcium excretion (p<0.05). The effect of L-NAME was markedly reduced by bosentan (10 mg/kg b.w. i.v.) and the values of urine flow rate, sodium, chloride and calcium excretions returned to control level (p<0.05). L-NAME administration one week after a bilateral renal denervation increased blood pressure to a similar extent as in sham-operated rats but decreased urine flow rate (p<0.05) and did not change electrolyte excretion. ET(A/)ET(B) receptor inhibition with bosentan during NO synthase inhibition in the renal denervated rats did not produce changes in urine flow rate or electrolyte excretion. NO synthase inhibition as well as concurrent NO synthase and ET(A/)ET(B) receptor inhibition did not change clearance of inulin or paraaminohippuric acid in sham-operated or renal denervated rats. These results indicate that renal sympathetic nerves play an important modulatory role in NO and endothelin induced effects on renal excretory function.
Girchev
R
R
Department of Physiology, Medical University, Bulgaria. girchev@medfac.acad.bg
Markova
P
P
Vuchidolova
V
V
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D000077300:Bosentan; D002118:Calcium / Q000378:metabolism; D002712:Chlorides / Q000378:metabolism; D003714:Denervation; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007444:Inulin / Q000097:blood / Q000652:urine; D007668:Kidney / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012964:Sodium / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology
D002712:Chlorides; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D004791:Enzyme Inhibitors; D013449:Sulfonamides; D009569:Nitric Oxide; D007444:Inulin; D012964:Sodium; D019001:Nitric Oxide Synthase; D000077300:Bosentan; D002118:Calcium; D019331:NG-Nitroarginine Methyl Ester